End organ protection by calcium-channel blockers (Q32051383)

5 July 2017

1 reference

title

End organ protection by calcium-channel blockers (English)

1 reference

5 July 2017

D Tzivoni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655250&resulttype=core&format=json

15 May 2020

publication date

1 February 2001

1 reference

5 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655250&resulttype=core&format=json

15 May 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655250&resulttype=core&format=json

15 May 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655250&resulttype=core&format=json

15 May 2020

page(s)

102-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655250&resulttype=core&format=json

Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240202

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240202

Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240202

Chronic amlodipine treatment during the development of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240202

Nifedipine Attenuates Systemic and Renal Vasoconstriction During Nitric Oxide Inhibition in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240202

Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine

21 January 2018

1 reference

12 December 2020

Calcium-antagonist drugs

1 reference

12 December 2020

Effect of Amlodipine Pretreatment on Ischaemia-Reperfusion-Induced Increase in Cardiac Endothelin-1 Binding Site Density

1 reference

12 December 2020

The antiatherogenic effects of amlodipine: promise of preclinical data

1 reference

12 December 2020

Effect of amlodipine on mesangial cell proliferation and protein synthesis

1 reference

12 December 2020

Protective effects of various calcium antagonists against experimental arteriosclerosis

1 reference

12 December 2020

Effects of nifedipine-GITS on left ventricular mass and left ventricular filling

1 reference

12 December 2020

Inhibition of human mesangial cell proliferation by calcium channel blockers

1 reference

12 December 2020

Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators

1 reference

12 December 2020

Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis

1 reference

12 December 2020

Nisoldipine inhibits lipid peroxidation induced by coronary occlusion in pig myocardium.

1 reference

12 December 2020

A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis

1 reference

12 December 2020

Experimental basis of the long-term therapy of arterial hypertension with calcium antagonists.

1 reference

12 December 2020

Antiperoxidant effects of dihydropyridine calcium antagonists

1 reference

12 December 2020

Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris

1 reference

12 December 2020

Antihypertensive and arterial anticalcinotic effects of calcium antagonists

1 reference

12 December 2020

Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?

1 reference

12 December 2020

Inhibition by nifedipine of the efflux of plasma low-density lipoprotein and albumin from the vasculature of the mouse mesentery in vivo

1 reference

12 December 2020

Limits of lipid-lowering therapy: the benefits of amlodipine as an anti-atherosclerotic agent.

1 reference

12 December 2020

Stimulated leukocyte adhesion in coronary microcirculation is reduced by a calcium antagonist

1 reference

12 December 2020

Effect of amlodipine on left ventricular mass in the Amlodipine Cardiovascular Community Trial.

1 reference

12 December 2020

Evidence for a synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis in symptomatic patients with normal to moderately raised cholesterol levels. The REGRESS Study Group

1 reference

12 December 2020

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

12 December 2020

Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors

1 reference

12 December 2020

Structure and function of resistance arteries of hypertensive patients treated with a beta-blocker or a calcium channel antagonist

1 reference

12 December 2020

Calcium antagonists and endothelial function: focus on nitric oxide and endothelin

1 reference

12 December 2020

Long-term effects of angiotensin-converting enzyme inhibitors and calcium antagonists on the right and left ventricles in essential hypertension

1 reference

12 December 2020

Renal protection in diabetes--an emerging role for calcium antagonists

1 reference

12 December 2020

Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin

1 reference

12 December 2020

Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent

1 reference

12 December 2020

Reversal of abnormal coronary vasomotion by calcium antagonists in patients with hypercholesterolemia

1 reference

12 December 2020

Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis

1 reference

12 December 2020

Randomized, double-blind crossover study to investigate the effects of amlodipine and isosorbide mononitrate on the time course and severity of exercise-induced myocardial stunning

1 reference

12 December 2020

Antioxidative action of the novel calcium channel antagonist mibefradil on low-density lipoproteins

1 reference

12 December 2020

Unique cardioprotective action of the new calcium antagonist mibefradil

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960240202

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655250&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655250&resulttype=core&format=json

15 May 2020

11214738

1 reference